Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study

Daniel Mol; Michelle D van der Stoel; Jippe C Balt; Rohit E Bhagwandien; Yuri Blaauw; Pascal F H M van Dessel; Vincent J H M van Driel; Antoine H G Driessen; Arif Elvan; Rutger J Hassink; Michiel J B Kemme; Karin Kraaier; Wichert J Kuijt; Justin G L M Luermans; Pepijn H van der Voort; Sjoerd W Westra; Joris R de Groot; Jonas S S G de Jong

doi:10.1016/j.cjca.2022.05.024

Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study

Daniel Mol^*, Michelle D van der Stoel, Jippe C Balt, Rohit E Bhagwandien, Yuri Blaauw, Pascal F H M van Dessel, Vincent J H M van Driel, Antoine H G Driessen, Arif Elvan, Rutger J Hassink, Michiel J B Kemme, Karin Kraaier, Wichert J Kuijt, Justin G L M Luermans, Pepijn H van der Voort, Sjoerd W Westra, Joris R de Groot, Jonas S S G de Jong

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

2 Downloads (Pure)

Abstract

This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.

Original language	English
Pages (from-to)	1616-1618
Journal	Canadian Journal of Cardiology
Volume	38
Issue number	10
DOIs	https://doi.org/10.1016/j.cjca.2022.05.024
Publication status	E-pub ahead of print - 13 Jun 2022

Access to Document

10.1016/j.cjca.2022.05.024

Full TextProof, 166 KBLicence: Taverne

Cite this

Mol, D., van der Stoel, M. D., Balt, J. C., Bhagwandien, R. E., Blaauw, Y., van Dessel, P. F. H. M., van Driel, V. J. H. M., Driessen, A. H. G., Elvan, A., Hassink, R. J., Kemme, M. J. B., Kraaier, K., Kuijt, W. J., Luermans, J. G. L. M., van der Voort, P. H., Westra, S. W., de Groot, J. R., & de Jong, J. S. S. G. (2022). Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study. Canadian Journal of Cardiology, 38(10), 1616-1618. https://doi.org/10.1016/j.cjca.2022.05.024

@article{2107aac120bd4d6289a42cfeb0d4b469,

title = "Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study",

abstract = "This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.",

author = "Daniel Mol and {van der Stoel}, {Michelle D} and Balt, {Jippe C} and Bhagwandien, {Rohit E} and Yuri Blaauw and {van Dessel}, {Pascal F H M} and {van Driel}, {Vincent J H M} and Driessen, {Antoine H G} and Arif Elvan and Hassink, {Rutger J} and Kemme, {Michiel J B} and Karin Kraaier and Kuijt, {Wichert J} and Luermans, {Justin G L M} and {van der Voort}, {Pepijn H} and Westra, {Sjoerd W} and {de Groot}, {Joris R} and {de Jong}, {Jonas S S G}",

note = "Copyright {\textcopyright} 2022. Published by Elsevier Inc.",

year = "2022",

month = jun,

day = "13",

doi = "10.1016/j.cjca.2022.05.024",

language = "English",

volume = "38",

pages = "1616--1618",

journal = "Canadian Journal of Cardiology",

issn = "0828-282X",

publisher = "Pulsus Group Inc.",

number = "10",

}

Mol, D, van der Stoel, MD, Balt, JC, Bhagwandien, RE, Blaauw, Y, van Dessel, PFHM, van Driel, VJHM, Driessen, AHG, Elvan, A, Hassink, RJ, Kemme, MJB, Kraaier, K, Kuijt, WJ, Luermans, JGLM, van der Voort, PH, Westra, SW, de Groot, JR & de Jong, JSSG 2022, 'Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration: NHR-AF Mortality Study', Canadian Journal of Cardiology, vol. 38, no. 10, pp. 1616-1618. https://doi.org/10.1016/j.cjca.2022.05.024

TY - JOUR

T1 - Low 30-day Mortality after Atrial Fibrillation Ablation; Results from the Netherlands Heart Registration

T2 - NHR-AF Mortality Study

AU - Mol, Daniel

AU - van der Stoel, Michelle D

AU - Balt, Jippe C

AU - Bhagwandien, Rohit E

AU - Blaauw, Yuri

AU - van Dessel, Pascal F H M

AU - van Driel, Vincent J H M

AU - Driessen, Antoine H G

AU - Elvan, Arif

AU - Hassink, Rutger J

AU - Kemme, Michiel J B

AU - Kraaier, Karin

AU - Kuijt, Wichert J

AU - Luermans, Justin G L M

AU - van der Voort, Pepijn H

AU - Westra, Sjoerd W

AU - de Groot, Joris R

AU - de Jong, Jonas S S G

PY - 2022/6/13

Y1 - 2022/6/13

N2 - This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.

AB - This study presents the 30-day mortality of patients who underwent atrial fibrillation (AF) ablation between 2013 - 2020 and were registered in the Netherlands Heart Registration. In total, 30,197/30,238 (99.9%) patients were analyzed. Fifteen (0.05%) died within 30 days. Nine deaths were considered procedurally related, four were considered non-procedural related, and in two patients the cause of death was unknown.

U2 - 10.1016/j.cjca.2022.05.024

DO - 10.1016/j.cjca.2022.05.024

M3 - Article

C2 - 35709933

SN - 0828-282X

VL - 38

SP - 1616

EP - 1618

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

IS - 10

ER -